Aziyo Biologics will provide ViBone® cellular bone matrix to RTI Surgical for exclusive distribution in the U.S. Further, the companies will partner on new research for the product.
ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to protect and preserve the health of native bone cells, thus potentially enhancing new bone formation.
Aziyo Biologics will provide ViBone® cellular bone matrix to RTI Surgical for exclusive distribution in the U.S. Further, the companies will partner on new research for the product.
ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to...
Aziyo Biologics will provide ViBone® cellular bone matrix to RTI Surgical for exclusive distribution in the U.S. Further, the companies will partner on new research for the product.
ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to protect and preserve the health of native bone cells, thus potentially enhancing new bone formation.
Copy to clipboard 
